OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 214,190 results

Filters: MELANOMA

Metastatic melanoma and rare melanoma variants: a review.
Lori Lowe
Pathology. Mar, 2023.55(2):236-244 Print-Electronic
Source:PubMed
PMID: 36641376 doi:10.1016/j.pathol.2022.11.006
Thirty years of therapeutic innovation in melanoma research.
Ferdy J Lejeune, Walter J Storkus, Patrick A Riley
Melanoma Res. 04 01, 2021.31(2):105-107 Print
Source:PubMed
PMID: 33625105 doi:10.1097/CMR.0000000000000723
[Clinical aspects and pathology of melanoma].
R G Panizzon, D Guggisberg
Ther Umsch. Jun, 1999.56(6):302-8 Print
Source:PubMed
PMID: 10420811 doi:10.1024/0040-5930.56.6.302
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer; Nivolumab and Ipilimumab in Advanced Melanoma; Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma; Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy; Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma; Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma; Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma; Rapid Eradication of a Bulky Melanoma Mass with One Dose of Immunotherapy; Genetic Basis for Clinical Response to CTLA-4 Blockade; Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma; Nivolumab plus Ipilimumab in Advanced Melanoma; Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma; Hepatotoxicity with Combination of Vemurafenib and Ipilimumab.
No authors listed
N Engl J Med. Nov 29, 2018.379(22):2185 Print-Electronic
Source:PubMed
PMID: 31442371 doi:10.1056/NEJMx180040
Risk of subsequent melanoma after melanoma in situ and invasive melanoma: a population-based study from 1973 to 2011.
Hyemin Pomerantz, David Huang, Martin A Weinstock
J Am Acad Dermatol. May, 2015.72(5):794-800 Print-Electronic
Source:PubMed
PMID: 25769192 doi:10.1016/j.jaad.2015.02.006
Desmoplastic melanoma: a review of its pathology and clinical behaviour, and of management recommendations in published guidelines.
T M Hughes, G J Williams, D E Gyorki, J W Kelly, J R Stretch, A H R Varey, A M Hong, R A Scolyer, J F Thompson
J Eur Acad Dermatol Venereol. Jun, 2021.35(6):1290-1298 Print-Electronic
Source:PubMed
PMID: 33544941 doi:10.1111/jdv.17154
Epigenetic marks in melanoma.
Hunter W Richards, Estela E Medrano
Pigment Cell Melanoma Res. Feb, 2009.22(1):14-29 Print-Electronic
Source:PubMed
PMID: 19040501 doi:10.1111/j.1755-148X.2008.00534.x
Efficacy of Electrochemotherapy in the Treatment of Cutaneous Melanoma Metastases and Rare Non-melanoma Skin Cancer.
Lorenzo Borgognoni, Leonardo Pescitelli, Gianni Gerlini, Paola Brandani, Riccardo Gelli, Vanni Giannotti, Francesco Bellucci, Serena Sestini
Anticancer Res. Nov, 2020.40(11):6485-6492 Print
Source:PubMed
PMID: 33109587 doi:10.21873/anticanres.14670
[Trypanosoma cruzi infection decreases malignant melanoma development and increases survival in C57BL/6 mice].
Daniela Alejandra Morillo, Beatriz Elena González, Adriana Josefina Sulbarán Larrarte, Alba Ibarra, Carmen Alvarez, María Victoria Colmenares, Rafael Armando Bonfante-Cabarcas
Invest Clin. Sep, 2014.55(3):227-37 Print
Source:PubMed
PMID: 25272522 doi:
Melanoma of the Skin in the Danish Cancer Registry and the Danish Melanoma Database: A Validation Study.
Sidsel Arnspang Pedersen, Sigrun Alba Johannesdottir Schmidt, Siri Klausen, Anton Pottegård, Søren Friis, Lisbet Rosenkrantz Hölmich, David Gaist
Epidemiology. 05, 2018.29(3):442-447 Print
Source:PubMed
PMID: 29337844 doi:10.1097/EDE.0000000000000802
0